Evaluation of chronic lymphocytic leukemia by oligonucleotide-based microarray analysis uncovers novel aberrations not detected by FISH or cytogenetic analysis

Molecular Cytogenetics

Volumn 4, Issue 1, 2011, Pages

  Kolquist, Kathryn A ^a   Schultz, Roger A ^b   Slovak, Marilyn L ^b,e   McDaniel, Lisa D ^a,b   Brown, Theresa C ^c   Tubbs, Raymond R ^d   Cook, James R ^d   Theil, Karl S ^d   Cawich, Victoria ^b   Valentin, Caitlin ^b   Minier, Sara ^b   Neill, Nicholas J ^b   Byerly, Steve ^b   Morton, S ^b   Sahoo, Trilochan ^b,e   Ballif, Blake C ^b   Shaffer, Lisa G ^b  

^a SACRED HEART MEDICAL CENTER   (United States)

^b PERKINELMER INC   (United States)

^c CSI Laboratories   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

chromosome aberration; chronic lymphocytic leukemia; cytogenetics; FISH; microarray; oligonucleotide

Indexed keywords

APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CHRONIC LYMPHATIC LEUKEMIA; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; KARYOTYPE; PRIORITY JOURNAL;

EID: 81055149867     PISSN: None     EISSN: 17558166     Source Type: Journal    
DOI: 10.1186/1755-8166-4-25     Document Type: Article

References (36)

1. Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia. Patel A, Kang SH, Lennon PA, Li YF, Rao PN, Abruzzo L, Shaw C, Chinault AC, Cheung SW, Am J Hematol 2008 83 7 540 546 10.1002/ajh.21145 18161787 (Pubitemid 351874869)
2. Clinical application of array-based comparative genomic hybridization for the identification of prognostically important genetic alterations in chronic lymphocytic leukemia. Higgins RA, Gunn SR, Robetorye RS, Mol Diagn Ther 2008 12 5 271 280 18803425
3. Clinical staging of chronic lymphocytic leukemia. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS, Blood 1975 46 2 219 234 1139039
4. A critical analysis of staging in CLL. Rai KR, Chronic lymphocytic leukemia: recent progress, future direction New York: Alan R. Liss, Gale RP, Rai KR, 1987 253
5. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Monconduit M, Belabbes S, Gremy F, Cancer 1981 48 1 198 206 10.1002/1097-0142(19810701)48:1<198:: AID-CNCR2820480131>3.0.CO;2-V 7237385 (Pubitemid 11064396)
6. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N, Blood 1999 94 6 1840 1847 10477712 (Pubitemid 29430399)
7. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK, Blood 1999 94 6 1848 1854 10477713 (Pubitemid 29430400)
8. Predicting clinical outcome in CLL: how and why. Shanafelt TD, Hematology Am Soc Hematol Educ Program 2009 421 429
9. Whole genome scanning as a cytogenetic tool in hematologic malignancies. Maciejewski JP, Mufti GJ, Blood 2008 112 4 965 974 10.1182/blood-2008-02-130435 18505780
10. All you need is a Mir-acle: the role of nontranslated RNAs in the suppression of B cell chronic lymphocytic leukemia. Lichter P, Cancer Cell 2010 17 1 3 4 10.1016/j.ccr.2009.12.029 20129242
11. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Klein U, Lia M, Crespo M, Siegel R, Shen Q, Mo T, Ambesi-Impiombato A, Califano A, Migliazza A, Bhagat G, Dalla-Favera R, Cancer Cell 2010 17 1 28 40 10.1016/j.ccr.2009.11.019 20060366
12. 13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia. Parker H, Rose-Zerilli MJ, Parker A, Chaplin T, Wade R, Gardiner A, Griffiths M, Collins A, Young BD, Oscier DG, Strefford JC, Leukemia 2011 25 3 489 497 10.1038/leu.2010.288 21151023
13. Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemia. Sellmann L, Gesk S, Walter C, Ritgen M, Harder L, Martin-Subero JI, Schroers R, Siemer D, Nuckel H, Dyer MJ, Duhrsen U, Siebert R, Durig J, Kuppers R, Br J Haematol 2007 138 2 217 220 10.1111/j.1365-2141. 2007.06636.x 17593029 (Pubitemid 46976322)
14. Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis. Cuneo A, Rigolin GM, Bigoni R, De Angeli C, Veronese A, Cavazzini F, Bardi A, Roberti MG, Tammiso E, Agostini P, Ciccone M, Della Porta M, Tieghi A, Cavazzini L, Negrini M, Castoldi G, Leukemia 2004 18 3 476 483 10.1038/sj.leu.2403242 14712287 (Pubitemid 38425861)
15. Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer Center. Tsimberidou AM, Wen S, O'Brien S, McLaughlin P, Wierda WG, Ferrajoli A, Faderl S, Manning J, Lerner S, Mai CV, Rodriguez AM, Hess M, Do KA, Freireich EJ, Kantarjian HM, Medeiros LJ, Keating MJ, J Clin Oncol 2007 25 29 4648 4656 10.1200/JCO.2006.09.4508 17925562 (Pubitemid 350041550)
16. Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion. Forconi F, Rinaldi A, Kwee I, Sozzi E, Raspadori D, Rancoita PM, Scandurra M, Rossi D, Deambrogi C, Capello D, Zucca E, Marconi D, Bomben R, Gattei V, Lauria F, Gaidano G, Bertoni F, Br J Haematol 2008 143 4 532 536 18752589
17. Chronic lymphocytic leukemia. Byrd JC, Stilgenbauer S, Flinn IW, Hematology Am Soc Hematol Educ Program 2004 163 183
18. +18 or trisomy 18 in lymphoproliferative disorders. Van Dyke DL, http://AtlasGeneticsOncology.org/Anomalies/Tri18ID2030.html
19. Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA). Grubor V, Krasnitz A, Troge JE, Meth JL, Lakshmi B, Kendall JT, Yamrom B, Alex G, Pai D, Navin N, Hufnagel LA, Lee YH, Cook K, Allen SL, Rai KR, Damle RN, Calissano C, Chiorazzi N, Wigler M, Esposito D, Blood 2009 113 6 1294 1303 10.1182/blood-2008-05-158865 18922857
20. Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia. Sargent R, Jones D, Abruzzo LV, Yao H, Bonderover J, Cisneros M, Wierda WG, Keating MJ, Luthra R, J Mol Diagn 2009 11 1 25 34 10.2353/jmoldx.2009.080037 19074592
21. Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays. Hagenkord JM, Monzon FA, Kash SF, Lilleberg S, Xie Q, Kant JA, J Mol Diagn 2010 12 2 184 196 10.2353/jmoldx.2010.090118 20075210
22. GSTT1 and GSTM1 polymorphisms and myelodysplastic syndrome risk: a systematic review and meta-analysis. Dahabreh IJ, Giannouli S, Gota V, Voulgarelis M, Int J Cancer 2010 126 7 1716 1723 19816935
23. A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia. Van Dyke DL, Shanafelt TD, Call TG, Zent CS, Smoley SA, Rabe KG, Schwager SM, Sonbert JC, Slager SL, Kay NE, Br J Haematol 2010 148 4 544 550 10.1111/j.1365-2141.2009. 07982.x 19895615
24. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC, EMBO J 1999 18 19 5242 5251 10.1093/emboj/18.19.5242 10508158 (Pubitemid 29465575)
25. A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Akagi T, Motegi M, Tamura A, Suzuki R, Hosokawa Y, Suzuki H, Ota H, Nakamura S, Morishima Y, Taniwaki M, Seto M, Oncogene 1999 18 42 5785 5794 10.1038/sj.onc.1203018 10523859 (Pubitemid 29507432)
26. The novel NF-[kappa]B inhibitor IMD-0354 induces apoptosis in chronic lymphocytic leukemia. Kanduri M, Tobin G, Aleskog A, Nilsson K, Rosenquist R, Blood Cancer Journal 2011 1 12 10.1038/bcj.2011.9
27. Atypical 11q deletions identified by array CGH may be missed by FISH panels for prognostic markers in chronic lymphocytic leukemia. Gunn SR, Hibbard MK, Ismail SH, Lowery-Nordberg M, Mellink CH, Bahler DW, Abruzzo LV, Enriquez EL, Gorre ME, Mohammed MS, Robetorye RS, Leukemia 2009 23 5 1011 1017 10.1038/leu.2008.393 19158838
28. GSTT1 (glutathione S-transferase theta 1). Dessen P, Le Minor S, http://atlasgeneticsoncology.org/Genes/GC-GSTT1.html
29. Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia. Yuille M, Condie A, Hudson C, Kote-Jarai Z, Stone E, Eeles R, Matutes E, Catovsky D, Houlston R, Blood 2002 99 11 4216 4218 10.1182/blood.V99.11.4216 12010828 (Pubitemid 35332068)
30. Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME gene. Gunn SR, Bolla AR, Barron LL, Gorre ME, Mohammed MS, Bahler DW, Mellink CH, van Oers MH, Keating MJ, Ferrajoli A, Coombes KR, Abruzzo LV, Robetorye RS, Leuk Res 2009 33 9 1276 1281 10.1016/j.leukres.2008.10.010 19027161
31. Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation. Okazaki N, Takahashi N, Kojima S, Masuho Y, Koga H, Carcinogenesis 2002 23 7 1139 1148 10.1093/carcin/23.7.1139 12117771 (Pubitemid 34814771)
32. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Georgantas RW, Hildreth R, Morisot S, Alder J, Liu CG, Heimfeld S, Calin GA, Croce CM, Civin CI, Proc Natl Acad Sci USA 2007 104 8 2750 2755 10.1073/pnas.0610983104 17293455 (Pubitemid 46327951)
33. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. Holzelova E, Vonarbourg C, Stolzenberg MC, Arkwright PD, Selz F, Prieur AM, Blanche S, Bartunkova J, Vilmer E, Fischer A, Le Deist F, Rieux-Laucat F, N Engl J Med 2004 351 14 1409 1418 10.1056/NEJMoa040036 15459302 (Pubitemid 39288167)
34. The cdc25 protein contains an intrinsic phosphatase activity. Dunphy WG, Kumagai A, Cell 1991 67 1 189 196 10.1016/0092-8674(91)90582-J 1655274 (Pubitemid 121001435)
35. SEER Cancer Statistics Review, 1975-2007. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK, http://seer.cancer.gov/csr/1975-2007/
36. Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. Mauro FR, Foa R, Giannarelli D, Cordone I, Crescenzi S, Pescarmona E, Sala R, Cerretti R, Mandelli F, Blood 1999 94 2 448 454 10397712 (Pubitemid 29323859)